Status:
TERMINATED
Normoglycemia and Neurological Outcome
Lead Sponsor:
University of Louisville
Conditions:
Acute, Non-traumatic Subarachnoid Hemorrhage
Intraparenchymal Hemorrhage
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
Brain injury patients who meet defined criteria will be assigned to intensive insulin treatment (target blood glucose levels of 10-110 mg/dl) or conventional IV insulin treatment (target glucose of 15...
Detailed Description
Demographic data, social and medical histories, and clinical features at onset will be obtained via patient or family interview shortly after admission . We want to get the patients enrolled in our pr...
Eligibility Criteria
Inclusion
- non-traumatic SAH, ICH, or TBI
- Glasgow Coma Scale between 6 and 14
- admitted to an ICU of University of Louisville Hospital
Exclusion
- Patients \<18 and \>80 years
- GCS Motor score \<4 or an overall GCS score of 15
- diabetic patients who suffer from dialysis-dependent diabetic nephropathy
- patients with multiple injuries
- patients who would have been classified as ASA 3 status prior to their acute neurological event
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2015
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT01137773
Start Date
January 1 2007
End Date
December 1 2015
Last Update
January 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Louisville Hospital
Louisville, Kentucky, United States, 40202